Maria Dolores P. C.
- Country
- Spain
- Department
- Neurology
Research Overview
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Phase 3 Randomized Double-Blind Study of Orelabrutinib for Primary Progressive Multiple Sclerosis in Patients With PPMS
- Phase 3 Randomized Double‑Blind Study of Orelabrutinib vs Placebo on Disability Progression in Non‑Active Secondary Progressive Multiple Sclerosis
Data & Insights
Has run more than one trial at 142 of 310 partner sites.
Specializations
Neurological Disorders
This investigator specializes in treating multiple sclerosis, with particular emphasis on its relapsing forms. Their research encompasses both relapsing-remitting multiple sclerosis (RRMS) and broader manifestations of the condition.
- Multiple Sclerosis Management
- Relapse Prevention Strategies
- Neurological Disease Progression
The investigator's work focuses on evaluating novel therapeutic approaches for multiple sclerosis treatment.
Therapeutic Innovation
Their research interests include investigating innovative treatment modalities for multiple sclerosis, particularly comparing emerging therapies with established treatments. The investigator evaluates both novel compounds and biosimilar medications.
- Comparative Treatment Studies
- Novel Therapeutic Agents
- Biosimilar Development
The work encompasses evaluation of therapeutic efficacy and safety profiles in neurological conditions.
Clinical Assessment
The investigator's expertise extends to clinical evaluation methods in multiple sclerosis, including assessment of disease activity through various clinical and imaging parameters.
- Disease Activity Monitoring
- Treatment Response Assessment
- Clinical Safety Evaluation
Their work includes monitoring therapeutic responses and evaluating treatment outcomes in multiple sclerosis patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.